| Detected | Trial | Change |
|---|---|---|
| 2026-06-02 | NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-02 | NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer |
Enrollment reduced: 270 -> 192 participants |
| 2026-06-02 | NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer |
Trial sites reduced: 100 -> 89 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05211895 | A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent… | Non-Small Cell Lung Cancer | Recruiting |
| NCT05502237 | Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT05568095 | A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus… | Advanced Upper Gastrointestinal Tract Adenocarcinoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT03547973 | Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be… | Metastatic Urothelial Cancer | Recruiting |
| NCT06727565 | Study of Novel Treatment Combination Therapies in Participants With Head and Neck… | Head and Neck Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT06133517 | PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive… | Urothelial Bladder Carcinoma | Active, Not Recruiting |
| NCT05130177 | Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1… | Melanoma | Active, Not Recruiting |
| NCT04736173 | Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer | Non Small Cell Lung Cancer | Active, Not Recruiting |
| NCT05633667 | Study of Novel Treatment Combinations in Patients With Lung Cancer | Lung Cancer | Active, Not Recruiting |
| NCT05676931 | Study With Various Immunotherapy Treatments in Participants With Lung Cancer | Advanced Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT05329766 | A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in… | Gastrointestinal Tract Malignancies | Active, Not Recruiting |
| NCT04791839 | Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and… | Non Small Cell Lung Cancer | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT04656535 | AB154 Combined With AB122 for Recurrent Glioblastoma | Glioblastoma | Active, Not Recruiting |